TKI 258 in Von Hippel-Lindau Syndrome (VHL)

This study has been terminated.
(Trial met toxicity stopping rule)
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01266070
First received: December 22, 2010
Last updated: December 23, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)